Schroder Investment Management Group
IRWD icon

Schroder Investment Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Schroder Investment Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,256
Closed -$291K – 1226
2023
Q3 		$291K Buy
+30,256
New +$297K ﹤0.01% 1142
2023
Q2 		– Sell
-98,445
Closed -$1.04M – 1257
2023
Q1 		$1.04M Sell
98,445
-247,764
-72% -$2.78M ﹤0.01% 1053
2022
Q4 		$4.29M Sell
346,209
-155,368
-31% -$1.76M 0.01% 806
2022
Q3 		$5.2M Buy
501,577
+476,201
+1,877% +$5.4M 0.01% 764
2022
Q2 		$293K Sell
25,376
-9,618
-27% -$113K ﹤0.01% 1233
2022
Q1 		$451K Sell
34,994
-78,240
-69% -$897K ﹤0.01% 1231
2021
Q4 		$1.32M Sell
113,234
-70,840
-38% -$869K ﹤0.01% 997
2021
Q3 		$2.4M Hold
184,074
– – ﹤0.01% 943
2021
Q2 		$2.37M Buy
184,074
+86,029
+88% +$985K ﹤0.01% 982
2021
Q1 		$1.1M Sell
98,045
-13,288
-12% -$140K ﹤0.01% 1142
2020
Q4 		$1.27M Buy
111,333
+3,522
+3% +$38.5K ﹤0.01% 1084
2020
Q3 		$1M Buy
+107,811
New +$1.07M ﹤0.01% 1016

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Schroder Investment Management Group's IRWD Position: Q4 2023 in Review

Schroder Investment Management Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 30,256 shares — an estimated $291K sold.

Schroder Investment Management Group first reported a position in IRWD in Q3 2020 and held it in 12 quarters. The position peaked at $5.2M in Q3 2022. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

  • Schroder Investment Management Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 30,256 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $291K.
  • Schroder Investment Management Group first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 12 quarters.
  • Schroder Investment Management Group's Ironwood Pharmaceuticals position peaked at $5.2M in Q3 2022.
  • 251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on Schroder Investment Management Group's 13F filing for Q4 2023, filed 14 Feb 2024.